Evaluating in Vivo AZA Incorporation in Mononuclear Cells Following Vidaza or CC486
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Myelodysplastic Syndromes
Related studies linked through entity extraction aliases.
Trial of AB-110 in Adults With Hematologic Malignancies Undergoing Cord Blood Transplantation
- Status
- COMPLETED
- Phase
- PHASE1
Differential Diagnostic of Immune ThrombocytoPenia (ITP) and Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- N/A
SGI-110 and Donor Lymphocyte Infusions (DLI) After Allogeneic Stem Cell Transplantation
- Status
- UNKNOWN
- Phase
- PHASE2
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Status
- RECRUITING
- Phase
- N/A
iCare 2: Personalized Genomic Mutation Informed Treatment of Patients With Myelodysplastic Syndromes
- Status
- WITHDRAWN
- Phase
- NA
Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Peripheral Blood Stem Cell Transplantation From Family Haploidentical Donors in Patients With Myelodysplastic Syndrome and Acute Leukemia Under Primary Prophylaxis With Posaconazole
- Status
- COMPLETED
- Phase
- PHASE2
A Phase Ib Study Evaluating the Safety and Tolerability of Vitamin C in Patients With Intermediate or High Risk Myelodysplastic Syndrome With TET2 Mutations
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
RIC Regimen for Elderly or High Comorbidity Burden Patients Receiving Haplo-HSCT
- Status
- RECRUITING
- Phase
- PHASE2
RIC Regimen for Low- and Intermediate-risk MDS Receiving Haplo-HSCT
- Status
- UNKNOWN
- Phase
- PHASE2
Total Marrow and Lymphoid Irradiation and Chemotherapy for Myelodysplastic Syndrome or Acute Leukemia
- Status
- UNKNOWN
- Phase
- NA
TET2 Mutations in Myelodysplastic Syndromes and Acute Myeloid Leukemia With Azacitidine + Ascorbic Acid
- Status
- COMPLETED
- Phase
- PHASE2
CPX-351 Salvage Therapy Followed by Haplo-Cord Transplant for Relapsed/Refractory Leukemia or Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1
Decitabine and Arsenic Trioxide for Myelodysplastic Syndrome(MDS)
- Status
- WITHDRAWN
- Phase
- PHASE3
Flow Cytometric Analysis of Peripheral Blood Neutrophil Myeloperoxidase Expression and Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- N/A
Posaconazole Prophylaxis During ATG Treatment for hMDS/AA Patients
- Status
- COMPLETED
- Phase
- PHASE2
A Collaborative Palliative and Leukemia Care Model for Patients With AML and MDS Receiving Non-Intensive Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Study of ASTX727 vs IV Decitabine in Participants With MDS, CMML, and AML
- Status
- COMPLETED
- Phase
- PHASE3
Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2